Article
sTNFRII-Fc modification protects human UC-MSCs against apoptosis/autophagy induced by TNF-α and enhances their efficacy in alleviating inflammatory arthritis
2021-07-13
Abstract excerpt
<title>Abstract</title> <p>Background Tumor necrosis factor (TNF)-α inhibitors represented by etanercept (a fusion protein containing soluble TNF receptor Ⅱ (sTNFRⅡ) and the Fc segment of human IgG1) play a pivotal role in Rheumatoid arthritis (RA) treatment. However, long-term use increases the risk of infection and tumors for their systemic inhibition of TNF-α, which disrupts the regular physiological function...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4c30f5ed-6e49-52fd-90da-2306dc2299f4
- DOI
- 10.21203/rs.3.rs-695405/v1
